Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30022223HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS30022224HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS30022225HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS30022226HIVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS20003385HPVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS20047165HPVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS20037865HPVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS20043928HPVENSG00000198793.14protein_codingMTORYesNo2475P42345
TVIS44014774HTLV-1ENSG00000198793.14protein_codingMTORYesNo2475P42345
TCGA Plot Options
Drug Information
GeneMTOR
DrugBank IDDB06287
Drug NameTemsirolimus
Target IDBE0002386
UniProt IDP42345
Regulation Typeinhibitor
PubMed IDs18265991; 17935273; 11752352
CitationsPatard JJ, Pouessel D, Bensalah K, Culine S: Targeted therapy in renal cell carcinoma. World J Urol. 2008 Apr;26(2):135-40. doi: 10.1007/s00345-008-0237-4. Epub 2008 Feb 12.@@Radulovic S, Bjelogrlic SK: Sunitinib, sorafenib and mTOR inhibitors in renal cancer. J BUON. 2007 Sep;12 Suppl 1:S151-62.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsApproved
Direct ClassificationMacrolide lactams
SMILESOCC(C)(CO)C(=O)O[C@@H]1CC[C@@H](C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@@H](OC)C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)C[C@H]1OC
Pathways
PharmGKBPA164746890
ChEMBLCHEMBL1201182